Streptococcus pneumoniae antigens

Streptococcus pneumoniae antigens comprise a group of molecular structures, including capsular polysaccharides and surface proteins, that are critical for the survival and virulence of the pneumococcus bacterium. The capsular polysaccharide (CPS) is the most significant antigen, with over 100 known serotypes that provide a physical barrier against host phagocytosis by hindering complement deposition. Other vital protein antigens include pneumolysin (PLY), a potent pore-forming toxin that induces host cell death and inflammation, and pneumococcal surface protein A (PspA), which interferes with the host complement system to prevent bacterial clearance. These antigens serve as the primary targets for pneumococcal vaccines, which aim to induce a robust humoral immune response. By eliciting opsonizing antibodies, these therapeutics facilitate the recognition and destruction of the bacteria by immune cells, thereby preventing life-threatening conditions such as pneumonia, meningitis, and sepsis. Modern drug development is increasingly focused on conserved protein antigens to address the challenge of serotype replacement, where non-vaccine strains emerge to cause disease.

Other names

Pneumococcal antigensStreptococcus pneumoniae surface antigensPneumococcal virulence factorsCapsular polysaccharides (CPS)Pneumococcal surface proteins

Induction of a humoral immune response leading to the production of serotype-specific antibodies that promote opsonophagocytosis and neutralize bacterial toxins.